Grants for Promising Research in Hairy Cell Leukemia

Since 2016, we have partnered with the SASS Foundation for Medical Research to jointly fund up to $2 million in hairy cell leukemia research grants and fellowship awards through 2021.

Our primary research focus areas include:

• Basic science research exploring the biology of hairy cell leukemia;

• Correlative studies for biological and molecular markers associated with existing clinical trials where samples and clinical data are being collected; and

• Clinical research projects that contribute to studies providing real benefit for patients with hairy cell leukemia, including long-term follow-up studies, detailed quality of life studies, correlative lab studies and studies of new therapy options.

2019 RESEARCH GRANTEES

In 2019, we awarded $250,000 to exceptional researchers in hairy cell leukemia.

Andritsos+Headshot.jpg

Dr. Leslie Andritsos (pictured) and Dr. Claire Dearden*

University of New Mexico, Health Sciences Center, USA

*The Royal Marsden, UK

Ku%25CC%2588ppers%252C%2BRalf.jpg

Dr. Ralf Küppers

University of Duisburg-Essen, Germany

Zenz.jpg

Dr. Thorsten Zenz

University Hospital Zürich, Switzerland

PAST RESEARCH GRANTEES

2018 Grantees

blachly.jpeg

Dr. James Blachly

The Ohio State University, USA

christopher-y-park-square.jpg

Dr. Christopher Park

NYU School of Medicine, USA

Zenz.jpg

Dr. Thorsten Zenz

University Hospital Zürich, Switzerland

2017 Grantees

Dr. Leslie Andritsos, The Ohio State University, USA

Dr. Judit Demeter, Semmelweis University, Hungary

Dr. Christopher Oakes, The Ohio State University, USA

Dr. Enrico Tiacci, University of Perugia, Italy

2016 Grantees

Dr. Omar Abdel-Wahab, Memorial Sloan Kettering Cancer Center, USA

Drs. Brunangelo Falini and Enrico Tiacci, University of Perugia, Italy

Dr. Ralf Küppers, University of Duisburg-Essen, Germany

Dr. Philip Thompson, MD Anderson Cancer Center, USA


Expanding the Scope of our Research

In 2017, we began a partnership with the SASS Foundation for Medical Research and the Leukemia & Lymphoma Society to jointly support $1.2 million in new translational research over a 3-year period. Through this partnership, we are funding studies in chemotherapy-free treatment strategies for hairy cell leukemia with the potential to greatly improve therapy for patients.

Participating Researchers

Both researchers are conducting clinical trials for which they are actively seeking patients.

Learn more on our clinical trials page. >>

Dr. Jae Park   Memorial Sloan Kettering Cancer Center, USA

Dr. Jae Park

Memorial Sloan Kettering Cancer Center, USA

Dr. Enrico Tiacci   Institute of Hematology and Center for Hemato-Oncology Research, University of Perugia, Italy

Dr. Enrico Tiacci

Institute of Hematology and Center for Hemato-Oncology Research, University of Perugia, Italy